Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2016 2
2017 2
2018 1
2019 1
2020 1
2021 3
2022 10
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean zheng zhi liu[Author] (2 results)?
Microfluidics for Combating Antimicrobial Resistance.
Liu Z, Banaei N, Ren K. Liu Z, et al. Trends Biotechnol. 2017 Dec;35(12):1129-1139. doi: 10.1016/j.tibtech.2017.07.008. Epub 2017 Nov 15. Trends Biotechnol. 2017. PMID: 29153761 Review.
nMOWChIP-seq: low-input genome-wide mapping of non-histone targets.
Liu Z, Naler LB, Zhu Y, Deng C, Zhang Q, Zhu B, Zhou Z, Sarma M, Murray A, Xie H, Lu C. Liu Z, et al. NAR Genom Bioinform. 2022 Apr 7;4(2):lqac030. doi: 10.1093/nargab/lqac030. eCollection 2022 Jun. NAR Genom Bioinform. 2022. PMID: 35402909 Free PMC article.
A randomized, double-blind, single-dose, single-center, parallel phase I clinical study comparing the pharmacokinetics, immunogenicity, safety, and tolerance of pertuzumab injection and Perjeta® in healthy Chinese male subjects.
Liu G, Xu Z, Yang W, Xue J, Wang Y, Liu Z, Cui Y, Qu X, Chang T, Yu S, Cheng Y, Zhou Y, Chen J, Ren Q, Wang W, Deng Q, Wang Z, Yang H. Liu G, et al. Among authors: liu z. Expert Opin Biol Ther. 2022 Feb;22(2):187-195. doi: 10.1080/14712598.2021.1988567. Epub 2021 Oct 18. Expert Opin Biol Ther. 2022. PMID: 34607519 Clinical Trial.
A randomized, double-blind, single-dose, two-way, parallel phase I clinical study comparing the pharmacokinetics and safety of adalimumab injecta and Humira® in healthy Chinese male volunteers.
Wang Y, Gao Z, Liu Z, Liu G, Qu X, Chen J, Ren X, Xu Z, Yang H. Wang Y, et al. Among authors: liu z. Expert Opin Biol Ther. 2022 Feb;22(2):225-234. doi: 10.1080/14712598.2021.1944097. Epub 2021 Jun 30. Expert Opin Biol Ther. 2022. PMID: 34134579 Clinical Trial.
27 results